Cover Image
市場調查報告書

電子臨床解決方案世界市場預測 2022年:CDMS、電子DC、CTMS、電子COA、分析、RTSM、電子TMF、其他

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 249136
出版日期 內容資訊 英文 167 Pages
訂單完成後即時交付
價格
Back to Top
電子臨床解決方案世界市場預測 2022年:CDMS、電子DC、CTMS、電子COA、分析、RTSM、電子TMF、其他 eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022
出版日期: 2017年04月19日 內容資訊: 英文 167 Pages
簡介

世界電子臨床解決方案市場、2017年∼2022年預計將有12.4%CAGR (年複合成長率) 成長、2022年預估達76億1000萬美元規模。市場成長主因為數據標準化必要性、製藥企業與生技企業研究開發 (R&D) 投資擴大、新興國家市場實驗活動活絡化。另外、熟練專家不足、患者對隱私保護的不安感阻礙市場成長。

本報告針對世界電子臨床解決方案市場調查、提供產品、供應形態、實驗階段與使用者分類市場分析、4項主要地區市場分析、主要企業市場佔有率、策略、產品、流通網絡、製造能力評價。

第1章 介紹

第2章 調查方法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 介紹
  • 市場動態
    • 主要市場促進因素
      • 實驗運用成本上升與規範強化
      • 實驗用軟體方案的新規引進
      • 支援實驗的政府融資、補助金增加
      • 促進數據標準化的電子臨床解決方案普及
      • 製藥企業、生物藥品企業研究開發 (R&D) 投資擴大、創藥臨床實驗階段關IT支出金額
      • 電子臨床解決方案顧客層擴大
    • 主要市場阻礙因素
      • 電子臨床解決方案ソ導入成本ソ高イ
      • 電子臨床解決方案メ運用ザわペ熟練ウギ專門家ソ不足
      • 電子臨床解決方案ソ利點ズ關エペ、研究者ソ認識ソ低イ
    • 主要成長機會
      • 亞洲新興國家臨床研究活動活性化
      • 實驗流程外包:從企業內研究部門到CRO
      • 實驗數量增加 (特別是新興國家)
      • 從手動數據解釋轉為實驗中即時數據解析
    • 市場主要課題
      • 發展中國家的電子臨床解決方案使用限制
      • 軟體信賴性
      • 患者隱私

第6章 電子臨床解決方案市場:產品分類

  • 介紹
  • 電子數據收集 (電子DC)、臨床數據管理系統 (CDMS)
  • 實驗管理系統 (CTMS)
  • 臨床分析平台
  • 隨機實驗用品管理 (RTSM)
  • 臨床數據整合平台
  • 電子臨床結果評估 (電子COA)方案
  • 安全性方案
  • 電子臨床實驗主檔案 (電子TMF) 系統
  • 規制情報管理方案
  • 其他電子臨床解決方案

第7章 電子臨床解決方案市場:傳送形態分類

  • 介紹
  • 電子網站託管 (即時請求)方案
  • 認證式、企業(在地)方案
  • 雲端型 (SaaS)方案

第8章 電子臨床解決方案市場:實驗階段分類

  • 介紹
  • 第I階段
  • 第II階段
  • 第III階段
  • 第IV階段

第9章 電子臨床解決方案市場:使用者分類

  • 介紹
  • 醫藥品、生物藥品企業
  • 醫藥品開發業務委託機關 (CRO)
  • 諮詢服務企業
  • 醫療機器製造商
  • 醫院
  • 教育、研究機關

第10章 電子臨床解決方案市場:地區分類

  • 介紹
  • 北美 (美國、加拿大)
  • 歐洲
  • 亞太地區
  • 其他

第11章 競爭情況

  • 概要
  • 市場佔有率分析
  • 競爭狀況、動向
    • 協定、商業合作、事業協力
    • 產品引進
    • 產品發售、改良
    • 企業收購合併 (M&A)
    • 事業擴張
    • 其他策略

第12章 企業к①иャユю

  • 介紹
  • ORACLE CORPORATION
  • MEDIDATA SOLUTIONS, INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • BIOCLINICA, INC. (A SUBSIDIARY OF JLL PARTNERS)
  • DATATRAK INTERNATIONAL, INC.
  • CRF HEALTH
  • ERT CLINICAL
  • MERGE HEALTHCARE INCORPORATED
  • OMNICOMM SYSTEMS, INC.
  • MAXISIT INC.
  • BIO-OPTRONICS, INC.
  • ECLINICAL SOLUTIONS, LLC.

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 2208

The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. However, a dearth of skilled research professionals and concerns over patient data privacy are hampering the adoption of these solutions.

On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. The large market share of North America is attributed to the significant number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in the number of partnerships for new drug development, high prevalence of lifestyle diseases, and an increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting trials are negatively affecting the growth of the market in this region.

Although developed regions such as North America and Europe held large shares in the eClinical solutions market in 2016, it is the Asia-Pacific region that is poised to achieve the highest CAGR in the next five years. Factors such as the increasing outsourcing of clinical trial studies by large pharma and biopharma companies to Asia-Pacific countries, the presence of large patient population, and the low operating cost of conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2016. Partnerships, agreements, and collaborations; product launches, enhancements, and deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most players to achieve growth in the eClinical solutions market.

Research Coverage:

The report covers software solutions used across all phases in the clinical trial process. It aims at estimating the market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions. The report also includes an in-depth competitive analysis of the key players with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

This report focuses on various levels of analysis-market share analysis of the top players and company profiles, which discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner greater market shares. Companies purchasing the report could use any one of the combination of the strategies mentioned below, namely, market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the market. The report analyzes the eClinical solutions market, by product, delivery mode, clinical trial phase, and end users across four geographies.
  • Product Development/Innovation: Detailed insights on current technologies, research and development activities, and product launches in the eClinical solutions market.
  • Market Development: Comprehensive information of lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World).
  • Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MAJOR MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
      • 2.2.1.1. Bottom-up approach
      • 2.2.1.2. Top-down approach
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ECLINICAL SOLUTIONS: MARKET OVERVIEW
  • 4.2. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015KKKKK VS. 2015KKKKK VS. 2022KKKKK (USD MILLION)
  • 4.3. REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (2016)
  • 4.4. ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2017KKKKK VS. 2022)
  • 4.5. REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY END USER (2017-2022)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MAJOR MARKET DRIVERS
      • 5.2.1.1. Increasing operational costs and regulatory requirements associated with clinical research studies
      • 5.2.1.2. Growing adoption of novel software solutions in clinical research
      • 5.2.1.3. Rising government funding & grants to support clinical trials
      • 5.2.1.4. Growing adoption of eClinical solutions for improved data standardization
      • 5.2.1.5. Increasing R&D expenditure by pharma-biotech companies with augmented IT expenditure allocations for drug development pipeline
      • 5.2.1.6. Growing customer base for eClinical solutions
    • 5.2.2. MAJOR MARKET RESTRAINTS
      • 5.2.2.1. High implementation costs associated with eClinical solutions
      • 5.2.2.2. Dearth of skilled professionals for operating eClinical solutions
      • 5.2.2.3. Limited awareness among researchers related to advantages of eClinical solutions
    • 5.2.3. KEY GROWTH OPPORTUNITIES
      • 5.2.3.1. Increasing clinical research activities in emerging Asian countries
      • 5.2.3.2. Increased outsourcing of clinical trial processes by industrial researchers to CROs
      • 5.2.3.3. Rising number of clinical trials, especially across emerging countries
      • 5.2.3.4. Shift from manual data interpretation to real-time data analysis during clinical studies
    • 5.2.4. MAJOR MARKET CHALLENGES
      • 5.2.4.1. Limited adoption of eClinical solutions in developing nations
      • 5.2.4.2. Software reliability
      • 5.2.4.3. Patient privacy

6. GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
  • 6.3. CLINICAL TRIAL MANAGEMENT SYSTEMS
  • 6.4. CLINICAL ANALYTICS PLATFORMS
  • 6.5. RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
  • 6.6. CLINICAL DATA INTEGRATION PLATFORMS
  • 6.7. ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
  • 6.8. SAFETY SOLUTIONS
  • 6.9. ELECTRONIC TRIAL MASTER FILE SYSTEMS
  • 6.10. REGULATORY INFORMATION MANAGEMENT SOLUTIONS
  • 6.11. OTHER ECLINICAL SOLUTIONS

7. ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE

  • 7.1. INTRODUCTION
  • 7.2. WEB-HOSTED (ON-DEMAND) SOLUTIONS
  • 7.3. LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS
  • 7.4. CLOUD-BASED (SAAS) SOLUTIONS

8. GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

  • 8.1. INTRODUCTION
  • 8.2. PHASE I CLINICAL TRIALS
  • 8.3. PHASE II CLINICAL TRIALS
  • 8.4. PHASE III CLINICAL TRIALS
  • 8.5. PHASE IV CLINICAL TRIALS

9. ECLINICAL SOLUTIONS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 9.3. CONTRACT RESEARCH ORGANIZATIONS
  • 9.4. CONSULTING SERVICE COMPANIES
  • 9.5. MEDICAL DEVICE MANUFACTURERS
  • 9.6. HOSPITALS
  • 9.7. ACADEMIC RESEARCH INSTITUTES

10. ECLINICAL SOLUTIONS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.2. PRODUCT DEPLOYMENTS
    • 11.3.3. PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS
    • 11.3.4. MERGERS & ACQUISITIONS
    • 11.3.5. EXPANSIONS
    • 11.3.6. OTHER STRATEGIES

12. COMPANY PROFILES

  • 12.1. INTRODUCTION

(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*

  • 12.2. ORACLE CORPORATION
  • 12.3. MEDIDATA SOLUTIONS, INC.
  • 12.4. PAREXEL INTERNATIONAL CORPORATION
  • 12.5. BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN)
  • 12.6. DATATRAK INTERNATIONAL, INC.
  • 12.7. CRF HEALTH
  • 12.8. ERT CLINICAL
  • 12.9. MERGE HEALTHCARE INCORPORATED
  • 12.10. OMNICOMM SYSTEMS, INC.
  • 12.11. MAXISIT INC.
  • 12.12. BIO-OPTRONICS, INC.
  • 12.13. ECLINICAL SOLUTIONS, LLC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: U.S.: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2015
  • TABLE 2: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 3: GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015-2022 (USD MILLION)
  • TABLE 24: WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 28: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011-2015)
  • TABLE 39: ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 51: U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 52: CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 53: CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 54: EMA-APPROVED BIOSIMILARS
  • TABLE 55: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 56: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 63: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 64: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 65: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 66: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 67: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013-2017)
  • TABLE 68: PRODUCT DEPLOYMENTS (2013-2017)
  • TABLE 69: PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS (2013-2017)
  • TABLE 70: MERGERS & ACQUISITIONS (2013-2017)
  • TABLE 71: EXPANSIONS (2013-2017)
  • TABLE 72: OTHER STRATEGIES (2013-2017)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: ECLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH
  • FIGURE 4: ECLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: ECLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
  • FIGURE 7: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2016 (USD MILLION)
  • FIGURE 12: EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 13: EDC & CDMS SEGMENT TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2022
  • FIGURE 14: WEB-HOSTED DELIVERY MODE DOMINATED THE ECLINICAL SOLUTIONS MARKET ACROSS ALL REGIONAL SEGMENTS IN 2016
  • FIGURE 15: PHASE III CLINICAL TRIALS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: CONTRACT RESEARCH ORGANIZATIONS SEGMENT IN ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE
  • FIGURE 17: GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: EDC AND CDMS SEGMENT DOMINATED THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016
  • FIGURE 19: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR EDC AND CDMS SOLUTIONS MARKET IN 2017
  • FIGURE 20: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR CTMS MARKET DURING 2017-2022
  • FIGURE 21: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR CLINICAL ANALYTICS PLATFORMS MARKET IN 2017
  • FIGURE 22: ASIA-PACIFIC IS PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR RTSM SOLUTIONS MARKET TILL 2022
  • FIGURE 23: WEB-HOSTED SOLUTIONS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016
  • FIGURE 24: PHASE III TRIALS TO WITNESS HIGHEST DEMAND GROWTH FOR ECLINICAL SOLUTIONS DURING THE FORECAST PERIOD
  • FIGURE 25: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2016)
  • FIGURE 26: R&D EXPENDITURE OF TOP 8 PHARMACEUTICAL COMPANIES, 2013 VS. 2015 (USD MILLION)
  • FIGURE 27: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 28: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 29: EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 30: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012)
  • FIGURE 31: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 32: ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 33: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 34: GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS (2015)*
  • FIGURE 35: ORACLE CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 36: MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 37: PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 38: DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 39: MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT (2014)
  • FIGURE 40: OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT (2015)
Back to Top